Compositions and methods for treating prostate disorders
AssigneeSLGM Medical Research Institute
InventorJohn W. McDowell, Jr.
Life of this patent
Estimating the term…
Abstract
Compositions and methods are described for the treatment of prostatitis, benign prostatic hypertrophy, and prostate cancer. The compositions contain either aqueous extracts or dried mixtures of selenium- and zinc-enriched cannabis plant material, shiitake mushrooms, and maitake mushrooms. The compositions are effective in treating prostate disorders by alleviating pain and voiding symptoms, decreasing inflammation and prostate size, reducing cellular proliferation in prostate tissue, and/or reducing PSA levels to within the normal range of 0-4.
Claims16
A composition for treating prostatitis, benign prostatic hypertrophy, or prostate cancer, wherein the composition comprises a therapeutically effective amount of an aqueous extract of finely chopped dried selenium- and zinc-enhanced cannabis (Cannabis indica×Cannabis ruderalis), chopped shiitake mushrooms (Lentinula edodes), and chopped maitake mushrooms (Grifola frondosa).
A composition for treating prostate cancer, the composition comprising a therapeutically effective amount of a mixture of three components, wherein the three components are finely ground dried selenium- and zinc-enriched cannabis (Cannabis indica×Cannabis ruderalis), finely ground dried shiitake mushrooms (Lentinula edodes), and finely ground maitake mushrooms (Grifola frondosa).
A method of treating prostatitis, benign prostatic hypertrophy, or prostate cancer in a patient in need thereof, said method comprising administering a therapeutically effective amount of a composition comprising selenium- and zinc-enhanced cannabis (Cannabis indica×Cannabis ruderalis), shiitake mushrooms (Lentinula edodes), and maitake mushrooms (Grifola frondosa);
- or an aqueous extract thereof.
Dependencies are inferred from the claim text.